Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Ajinomoto Bio-Pharma Services (Aji Bio-Pharma), a leading provider of biopharmaceutical contract development and manufacturing services, announced the opening of a high-speed multi-purpose fill finish line in its state-of-the-art commercial ...
read more
Thursday, August 13, 2020
Ajinomoto Bio-Pharma has announced an expansion of small molecule manufacturing capabilities with the addition of a new production facility in India.
read more
Tuesday, January 25, 2022
Ajinomoto Bio-Pharma Services announced that Tony O'Neill has joined Aji Bio-Pharma as Vice President of Compliance, US Operations. Mr. O'Neill brings extensive experience leading Quality, Manufacturing, and Operational Excellence Teams in the ...
read more
Ajinomoto Bio-Pharma Services has entered into a manufacturing agreement with Humanigen for the fill finish supply of lenzilumab currently being studied in a trial for COVID-19.
read more
Thursday, October 01, 2020
Ajinomoto Bio-Pharma has announce a supply partnership with the DNDi for the supply of a CpG oligonucleotide, as part of a combination therapy used in the treatment of cutaneous leishmaniasis infections.
read more
Monday, December 28, 2020
Ajinomoto Bio-Pharma Services and Revance Therapeutics have announced a commercial manufacturing agreement for the supply of DaxibotulinumtoxinA for Injection.
read more
Wednesday, March 06, 2013
Ajinomoto Co., Inc. (“Ajinomoto Co.”; TYO: 2802) and Althea Technologies, Inc. (“Althea Technologies”), announced today that they have entered into a definitive agreement by which Ajinomoto Co. will acquire Althea Technologies, a leading provider of ...
read more
Akers Biosciences announced Premas Biotech, its partner in the development of a vaccine candidate that is seeking to address the COVID-19 pandemic, has successfully completed its vaccine prototype.
read more
Wednesday, August 08, 2012
Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today announced the appointment of Bruce Kutinsky as its Chief Operating Officer of its US operations effective September 1, 2012. Mr. Kutinsky was most recently the President of ...
read more
Akorn, Inc. (NASDAQ: AKRX) today announced that the U.S. Federal Trade Commission (FTC) has voted to approve Akorn’s acquisition of Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK). The unanimous vote in support of the transactions follows Akorn’s ...
read more
Akorn, Inc. and Hi-Tech Pharmacal Co., Inc. today announced that they have entered into a definitive agreement under which Akorn will acquire Hi-Tech for $640 million in cash.
read more
Akorn, Inc. today announced that it has entered into a definitive agreement to acquire VPI Holdings Corp., the parent company of VersaPharm Incorporated, for $440 million in cash.
read more
Akoya Biosciences announced the appointment of Pascal Bamford, PhD, as Sr. VP, Research and Development and Laboratory Operations. Dr. Bamford will be instrumental in accelerating the innovation of ground-breaking spatial biology solutions and the ...
read more
Akston Biosciences and LakePharma have established a strategic partnership.
read more
Wednesday, March 31, 2021
Albumedix announced they have entered into a distribution agreement with established and well recognized reagent supplier FUJIFILM Wako.
read more